These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

800 related items for PubMed ID: 17559576

  • 1. Interleukin-10 gene promoter polymorphisms and the risk of nasopharyngeal carcinoma.
    Wei YS, Kuang XH, Zhu YH, Liang WB, Yang ZH, Tai SH, Zhao Y, Zhang L.
    Tissue Antigens; 2007 Jul; 70(1):12-7. PubMed ID: 17559576
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Association of transforming growth factor-beta1 gene polymorphisms with genetic susceptibility to nasopharyngeal carcinoma.
    Wei YS, Zhu YH, Du B, Yang ZH, Liang WB, Lv ML, Kuang XH, Tai SH, Zhao Y, Zhang L.
    Clin Chim Acta; 2007 May 01; 380(1-2):165-9. PubMed ID: 17368597
    [Abstract] [Full Text] [Related]

  • 5. Association of variants in the interleukin-27 and interleukin-12 gene with nasopharyngeal carcinoma.
    Wei YS, Lan Y, Luo B, Lu D, Nong HB.
    Mol Carcinog; 2009 Aug 01; 48(8):751-7. PubMed ID: 19148899
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Interleukin-18 promoter polymorphism is associated with lung cancer: a case-control study.
    Farjadfar A, Mojtahedi Z, Ghayumi MA, Erfani N, Haghshenas MR, Ghaderi A.
    Acta Oncol; 2009 Aug 01; 48(7):971-6. PubMed ID: 19642044
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Functional IL-18 promoter gene polymorphisms in Tunisian nasopharyngeal carcinoma patients.
    Farhat K, Hassen E, Bouzgarrou N, Gabbouj S, Bouaouina N, Chouchane L.
    Cytokine; 2008 Aug 01; 43(2):132-7. PubMed ID: 18555694
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Functional polymorphisms and haplotypes in the promoter of the MMP2 gene are associated with risk of nasopharyngeal carcinoma.
    Zhou G, Zhai Y, Cui Y, Qiu W, Yang H, Zhang X, Dong X, He Y, Yao K, Zhang H, Peng Y, Yuan X, Zhi L, Zhang X, He F.
    Hum Mutat; 2007 Nov 01; 28(11):1091-7. PubMed ID: 17607721
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. The involvement of genetic polymorphism of IL-10 promoter in non-small cell lung cancer.
    Shih CM, Lee YL, Chiou HL, Hsu WF, Chen WE, Chou MC, Lin LY.
    Lung Cancer; 2005 Dec 01; 50(3):291-7. PubMed ID: 16122836
    [Abstract] [Full Text] [Related]

  • 18. A single nucleotide polymorphism in the E-cadherin gene promoter -160 C/A is associated with risk of nasopharyngeal cancer.
    Ben Nasr H, Hamrita B, Batbout M, Gabbouj S, Bouaouina N, Chouchane L, Chahed K.
    Clin Chim Acta; 2010 Sep 06; 411(17-18):1253-7. PubMed ID: 20462505
    [Abstract] [Full Text] [Related]

  • 19. Interleukin-10 promoter polymorphism is associated with decreased breast cancer risk.
    Langsenlehner U, Krippl P, Renner W, Yazdani-Biuki B, Eder T, Köppel H, Wascher TC, Paulweber B, Samonigg H.
    Breast Cancer Res Treat; 2005 Mar 06; 90(2):113-5. PubMed ID: 15803357
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 40.